Nao Medical

Nao Medical's Long Island City location in Astoria, New York is a REMS-certified facility providing FDA-approved Spravato (esketamine) for eligible adults with treatment-resistant depression and for adults with major depressive disorder experiencing acute suicidal thoughts. As an esketamine nasal spray, Spravato acts on the brain's glutamate system, offering an option when standard antidepressants have not provided enough relief.

Treatment includes clinical evaluation, benefits verification, prior authorization support, and monitored in-office dosing with post-dose observation, along with transportation planning for treatment days.

Eligible patients work with a dedicated care manager who coordinates authorization, scheduling, and logistics. The clinic gives Queens patients an accessible Spravato location, accepting major insurance including Medicaid, Medicare, and commercial plans.